Ault Family Dentistry | |
120 North 2nd Avenue Ault CO 80610 | |
(970) 834-2058 | |
Not Available |
Full Name | Ault Family Dentistry |
---|---|
Speciality | Dentist - General Practice |
Location | 120 North 2nd Avenue, Ault, Colorado |
Authorized Official Name and Position | Bradley William Eckhardt (OWNER) |
Authorized Official Contact | 9708342058 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Ault Family Dentistry Po Box 1038 Ault CO 80610-1038 Ph: (970) 834-2058 | Ault Family Dentistry 120 North 2nd Avenue Ault CO 80610 Ph: (970) 834-2058 |
NPI Number | 1003111618 |
---|---|
Provider Enumeration Date | 01/13/2011 |
Last Update Date | 01/13/2011 |
Identifier | Type | State | Issuer |
---|---|---|---|
1003111618 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | DEN9157 (Colorado) | Primary |
News Archive
A recent Finnish study showed that individualised and family-based lifestyle counselling helps 6-8-year-old children increase their physical activity levels and improve their diet quality during a two-year follow-up. The results of the study conducted at the University of Eastern Finland were recently published in Preventive Medicine.
With the infusion of an additional $1 million of financial support from The Susanne Marcus Collins Foundation, Inc., Atlanta, GA, Wake Forest Baptist Medical Center researchers are expanding their studies using a noninvasive, drugless therapy that may help to mitigate symptoms associated with a list of neurological conditions.
Although women with chronic hepatitis C virus (HCV) infection are at lower risk for developing cirrhosis, researchers who compared outcomes for men and women after having liver transplantation found that women have a significantly increased risk of overall graft loss and graft loss from recurrent HCV than men.
A recent analysis of two pivotal clinical trials in patients with acute low back pain (ALBP) who were treated with SOMA® (carisoprodol) 250 mg showed significantly improved functionality and reduced disability after three days of treatment, as measured by the Roland-Morris Disability Questionnaire (RMDQ).
› Verified 5 days ago